TOR Equity Snapshot

RVX Weekly Equity Report

Resverlogix Corp.

Interactive chart JSON snapshot
Latest Close 0.10 CAD 12 Jun 2026
1W Return 0.0% latest completed week
4W Return 0.0% short-term follow-through
12W Return -9.1% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
Company Brief

What the company does

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Snapshot

What the weekly tape is saying

RVX closed the latest completed week at 0.10 CAD. The 4-week return is 0.0% and the 12-week return is -9.1%. Trend Signal is inactive, Market Dynamics is -1.00. Setup signature: Risk-first tape with a 20/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.7%
Volume 0.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 36 Persistence of active Trend Signal over the last year and current streak.
Momentum 42 Blend of 4-week and 12-week follow-through.
Dynamics 33 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 7 Relative leadership and short-term RS change.
Volume 4 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
0.11 CAD
Vs Trend Line
-5.7%
Fair Value
0.08 CAD
Vs Fair Value
30.4%
52W High
0.30 CAD
52W Low
0.04 CAD
Drawdown
-66.7%
Range Position
23.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W 0.0%
12W -9.1%
26W -9.1%
52W 150.0%

Trend read

Active Streak
0 weeks
52W Active Weeks
34
52W Active Breadth
65.4%
Sector Scope
CA Healthcare
Sector Rank
19 of 46
Sector Percentile
60.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.00
4W MD Change
14.7%
Relative Strength
-11.94
4W RS Change
-84.4%
Expectation
Negative
Probability
17.51%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
13.0K
13W Average
145.0K
52W Average
353.6K
Vs 13W
0.1x
Vs 52W
0.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.1%
52W Volatility
26.3%
Upside Weeks
11
Downside Weeks
13
Downside Breadth
25.0%
Avg Gain / Loss
29.7% / -10.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
TOR
Country
CA
Sector
Healthcare
Industry
Biotechnology
Currency
CAD
Market Cap
30.1M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.00 -11.94 13.0K Off
5 Jun 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.01 -9.88 119.9K Off
29 May 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.05 -10.05 520.1K Off
22 May 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.17 -8.75 98.7K Off
15 May 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.18 -6.48 26.6K Off
8 May 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -1.05 -6.34 99.5K Off
1 May 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -0.74 -5.27 29.7K Off
24 Apr 2026 0.10 CAD 0.0% 0.11 CAD 0.08 CAD -0.40 -4.50 105.1K Off
17 Apr 2026 0.10 CAD -9.1% 0.11 CAD 0.08 CAD 0.00 -4.95 94.1K Off
10 Apr 2026 0.11 CAD 0.0% 0.11 CAD 0.08 CAD 0.30 7.43 72.8K On
3 Apr 2026 0.11 CAD 0.0% 0.11 CAD 0.08 CAD 0.44 10.43 80.7K On
27 Mar 2026 0.11 CAD 0.0% 0.11 CAD 0.08 CAD 0.64 15.25 329.9K On
20 Mar 2026 0.11 CAD -8.3% 0.11 CAD 0.08 CAD 0.40 18.71 294.5K On
13 Mar 2026 0.12 CAD -7.7% 0.10 CAD 0.08 CAD 0.18 25.86 251.8K On